company background image

Last Price

UK£14.15

Market Cap

UK£57.3b

7D

2.6%

1Y

-26.2%

Updated

01 Dec, 2022

Data

Company Financials +
GSK fundamental analysis
Snowflake Score
Valuation5/6
Future Growth4/6
Past Performance3/6
Financial Health3/6
Dividends6/6

GSK Stock Overview

GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally.

GSK plc Competitors

Price History & Performance

Summary of all time highs, changes and price drops for GSK
Historical stock prices
Current Share PriceUK£14.15
52 Week HighUK£34.08
52 Week LowUK£12.81
Beta0.32
1 Month Change-2.12%
3 Month Change4.69%
1 Year Change-26.19%
3 Year Change-33.66%
5 Year Change-11.23%
Change since IPO-39.67%

Recent News & Updates

Recent updates

Shareholder Returns

GSKGB PharmaceuticalsGB Market
7D2.6%2.6%1.0%
1Y-26.2%8.6%-6.0%

Return vs Industry: GSK underperformed the UK Pharmaceuticals industry which returned 8.6% over the past year.

Return vs Market: GSK underperformed the UK Market which returned -6% over the past year.

Price Volatility

Is GSK's price volatile compared to industry and market?
GSK volatility
GSK Average Weekly Movement3.4%
Pharmaceuticals Industry Average Movement5.8%
Market Average Movement5.8%
10% most volatile stocks in GB Market11.1%
10% least volatile stocks in GB Market2.8%

Stable Share Price: GSK is less volatile than 75% of UK stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: GSK's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
171590,096Emma Walmsleyhttps://www.gsk.com

GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology.

GSK plc Fundamentals Summary

How do GSK's earnings and revenue compare to its market cap?
GSK fundamental statistics
Market CapUK£57.30b
Earnings (TTM)UK£4.46b
Revenue (TTM)UK£38.44b

12.9x

P/E Ratio

1.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
GSK income statement (TTM)
RevenueUK£38.44b
Cost of RevenueUK£13.40b
Gross ProfitUK£25.04b
Other ExpensesUK£20.58b
EarningsUK£4.46b

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

Feb 01, 2023

Earnings per share (EPS)1.10
Gross Margin65.13%
Net Profit Margin11.59%
Debt/Equity Ratio253.7%

How did GSK perform over the long term?

See historical performance and comparison

Dividends

7.1%

Current Dividend Yield

69%

Payout Ratio